Jane Street’s Kalaris Therapeutics, Inc. Common Stock KLRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-5,355
| Closed | -$51.7K | – | 6916 |
|
|
2024
Q4 | $51.7K | Buy |
5,355
+1,731
| +48% | +$16.7K | ﹤0.01% | 5481 |
|
|
2024
Q3 | $67.4K | Sell |
3,624
-3,899
| -52% | -$72.5K | ﹤0.01% | 5561 |
|
|
2024
Q2 | $125K | Buy |
+7,523
| New | +$125K | ﹤0.01% | 5562 |
|
|
2024
Q1 | – | Sell |
-2,771
| Closed | -$43.3K | – | 6444 |
|
|
2023
Q4 | $43.3K | Buy |
2,771
+668
| +32% | +$10.4K | ﹤0.01% | 5422 |
|
|
2023
Q3 | $104K | Buy |
+2,103
| New | +$104K | ﹤0.01% | 4609 |
|
|
2023
Q2 | – | Sell |
-686
| Closed | -$62.2K | – | 6103 |
|
|
2023
Q1 | $62.2K | Sell |
686
-308
| -31% | -$27.9K | ﹤0.01% | 5071 |
|
|
2022
Q4 | $117K | Sell |
994
-189
| -16% | -$22.3K | ﹤0.01% | 4627 |
|
|
2022
Q3 | $215K | Sell |
1,183
-167
| -12% | -$30.4K | ﹤0.01% | 4509 |
|
|
2022
Q2 | $121K | Buy |
1,350
+904
| +203% | +$81K | ﹤0.01% | 4668 |
|
|
2022
Q1 | $69K | Buy |
+446
| New | +$69K | ﹤0.01% | 5069 |
|
|
2021
Q3 | – | Sell |
-825
| Closed | -$375K | – | 6043 |
|
|
2021
Q2 | $375K | Buy |
+825
| New | +$375K | ﹤0.01% | 3748 |
|
|
2020
Q4 | – | Sell |
-492
| Closed | -$311K | – | 4510 |
|
|
2020
Q3 | $311K | Buy |
+492
| New | +$311K | ﹤0.01% | 2834 |
|